Devorah Segal

906 total citations
23 papers, 319 citations indexed

About

Devorah Segal is a scholar working on Neurology, Surgery and Genetics. According to data from OpenAlex, Devorah Segal has authored 23 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 6 papers in Surgery and 5 papers in Genetics. Recurrent topics in Devorah Segal's work include Neuroblastoma Research and Treatments (6 papers), Glioma Diagnosis and Treatment (5 papers) and Functional Brain Connectivity Studies (4 papers). Devorah Segal is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Glioma Diagnosis and Treatment (5 papers) and Functional Brain Connectivity Studies (4 papers). Devorah Segal collaborates with scholars based in United States, Netherlands and Canada. Devorah Segal's co-authors include Patrick R. Hof, Matthias A. Karajannis, Christoph Schmitz, Heather E. Olson, Sriram Ramgopal, Alex R. Paciorkowski, Masanori Takeoka, Susan Koh, McKenna Kelly and Eric D. Marsh and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and NeuroImage.

In The Last Decade

Devorah Segal

20 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devorah Segal United States 8 89 80 76 68 54 23 319
Peter E. Davis United States 12 72 0.8× 41 0.5× 69 0.9× 42 0.6× 37 0.7× 16 547
Della Koovakkattu United States 8 80 0.9× 104 1.3× 53 0.7× 48 0.7× 40 0.7× 8 616
Mihaela Bustuchina ̆ Vlaicu France 7 114 1.3× 117 1.5× 121 1.6× 82 1.2× 59 1.1× 10 394
Luciana Ramalho Pimentel‐Silva Brazil 10 66 0.7× 107 1.3× 29 0.4× 44 0.6× 65 1.2× 27 274
Teemu Laitinen Finland 11 48 0.5× 87 1.1× 29 0.4× 189 2.8× 67 1.2× 11 386
Thomas Dorn Switzerland 13 139 1.6× 88 1.1× 113 1.5× 26 0.4× 160 3.0× 23 407
Josiane LaJoie United States 9 60 0.7× 167 2.1× 100 1.3× 23 0.3× 81 1.5× 12 508
Harald Stefanits Austria 12 98 1.1× 130 1.6× 22 0.3× 43 0.6× 145 2.7× 45 442
Philip H. Iffland United States 11 181 2.0× 107 1.3× 99 1.3× 15 0.2× 93 1.7× 17 377
Makoto Tomita Japan 11 99 1.1× 59 0.7× 97 1.3× 19 0.3× 90 1.7× 27 388

Countries citing papers authored by Devorah Segal

Since Specialization
Citations

This map shows the geographic impact of Devorah Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devorah Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devorah Segal more than expected).

Fields of papers citing papers by Devorah Segal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devorah Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devorah Segal. The network helps show where Devorah Segal may publish in the future.

Co-authorship network of co-authors of Devorah Segal

This figure shows the co-authorship network connecting the top 25 collaborators of Devorah Segal. A scholar is included among the top collaborators of Devorah Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devorah Segal. Devorah Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Segal, Devorah, et al.. (2025). Acute Effects of Pediatric Primary Brain Tumors. Pediatric Neurology. 167. 60–65. 1 indexed citations
2.
Kim, Kwang‐Soo, et al.. (2025). Autism and intellectual disability due to a novel gain-of-function mutation in UBE3A. Journal of Human Genetics. 70(8). 439–442. 1 indexed citations
3.
Yin, Lu, Steven G. Friedman, Devorah Segal, et al.. (2024). Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib. Pediatric Dermatology. 42(1). 67–72. 1 indexed citations
4.
Yohay, Kaleb, et al.. (2024). Identifying Lesions of the Corpus Callosum in Patients With Neurofibromatosis Type 1. Pediatric Neurology. 156. 66–71.
5.
Kline, Cassie, Angela J. Waanders, David S. Ziegler, et al.. (2024). Type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma (pLGG): Reversible decreases in growth velocity in the phase 2 FIREFLY-1 trial.. Journal of Clinical Oncology. 42(16_suppl). 10036–10036. 2 indexed citations
6.
Segal, Devorah, et al.. (2024). Isolated Cervical Cord Infarct in a Neonate. Journal of Child Neurology. 39(13-14). 521–526.
7.
Neifert, Sean N., David B. Kurland, Nora C. Kim, et al.. (2022). Management and surgical outcomes of dystrophic scoliosis in neurofibromatosis type 1: a systematic review. Neurosurgical FOCUS. 52(5). E7–E7. 6 indexed citations
8.
Miller, Claire A., et al.. (2022). A Case of Infant-Type Hemispheric Glioma with NTRK1 Fusion. SHILAP Revista de lepidopterología. 9. 2329048X221146982–2329048X221146982. 3 indexed citations
9.
Dinkin, Marc, Devorah Segal, Israel Zyskind, Cristiano Oliveira, & Grace Liu. (2021). Bilateral Optic Disc Edema in Multisystem Inflammatory Syndrome in Children Associated With COVID-19. Journal of Neuro-Ophthalmology. 42(1). e318–e322. 2 indexed citations
10.
Beck, David B., T. Subramanian, S. Vijayalingam, et al.. (2019). A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activity. Neurogenetics. 20(3). 129–143. 14 indexed citations
11.
Olson, Heather E., McKenna Kelly, Christopher M. LaCoursiere, et al.. (2017). Genetics and genotype–phenotype correlations in early onset epileptic encephalopathy with burst suppression. Annals of Neurology. 81(3). 419–429. 94 indexed citations
12.
Segal, Devorah, Sharon L. Gardner, David Zagzag, et al.. (2016). Utility of MRI versus tumor markers for post-treatment surveillance of marker-positive CNS germ cell tumors. Journal of Neuro-Oncology. 129(3). 541–544. 6 indexed citations
13.
Segal, Devorah & Matthias A. Karajannis. (2016). Pediatric Brain Tumors: An Update. Current problems in pediatric and adolescent health care. 46(7). 242–250. 24 indexed citations
14.
Segal, Devorah, Sharon L. Gardner, Jeffrey C. Allen, & Matthias A. Karajannis. (2016). EPT-21EFFICACY OF EVEROLIMUS IN PEDIATRIC BRAIN TUMORS: A SINGLE-INSTITUTION PATIENT SERIES. Neuro-Oncology. 18(suppl 3). iii28.3–iii28.
15.
Segal, Devorah, et al.. (2016). Severe holocord syrinx in a child with megalencephaly-capillary malformation syndrome. Journal of Neurosurgery Pediatrics. 18(1). 79–82. 6 indexed citations
16.
Bain, Jennifer, et al.. (2013). Call-Fleming Syndrome: Headache in a 16-Year-Old Girl. Pediatric Neurology. 49(2). 130–133.e1. 11 indexed citations
17.
Segal, Devorah, et al.. (2010). Cingulum bundle white matter in MAG-knockout mice. Translational Neuroscience. 1(2). 2 indexed citations
18.
Segal, Devorah, M. Mehmet Haznedar, Erin A. Hazlett, et al.. (2010). Diffusion tensor anisotropy in the cingulate gyrus in schizophrenia. NeuroImage. 50(2). 357–365. 29 indexed citations
19.
Segal, Devorah, Christoph Schmitz, & Patrick R. Hof. (2008). Spatial distribution and density of oligodendrocytes in the cingulum bundle are unaltered in schizophrenia. Acta Neuropathologica. 117(4). 385–394. 36 indexed citations
20.
Segal, Devorah, et al.. (2007). Oligodendrocyte pathophysiology: a new view of schizophrenia. The International Journal of Neuropsychopharmacology. 10(4). 503–503. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter E. Davis Breakdown of academic impact, for papers by Della Koovakkattu Breakdown of academic impact, for papers by Mihaela Bustuchina ̆ Vlaicu Breakdown of academic impact, for papers by Luciana Ramalho Pimentel‐Silva Breakdown of academic impact, for papers by Teemu Laitinen Breakdown of academic impact, for papers by Thomas Dorn Breakdown of academic impact, for papers by Josiane LaJoie Breakdown of academic impact, for papers by Harald Stefanits Breakdown of academic impact, for papers by Philip H. Iffland Breakdown of academic impact, for papers by Makoto Tomita
Rankless by CCL
2026